ndc for tirzepatide 00002-1471-80 — Mounjaro 10 mg/.5mL, 4 syringes FDA approval for Zepbound (tirzepatide)

In PD models, BDNF promotes the survival of dopaminergic neurons, enhances dopaminergic neurotransmission, and improves motor performance 29

Basic health screening should be conducted to check for conditions that make GLP-1 medications unsafe, such as certain thyroid conditions, pancreas problems, or severe digestive issues

Patients often find that nausea and digestive issues become less frequent and less intense

References SURMOUNT-1 Clinical Trial: The primary source for the weight loss data on tirzepatide, published in The New England Journal of Medicine

Psychiatry Times, Vol 42, Issue 7.) The potential for GLP-1 receptor agonists to impact addictive behaviors is certainly intriguing, particularly given the significant morbidity associated with substance use disorders